Cargando…
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) gains entry into the lung epithelial cells by binding to the surface protein angiotensin-converting enzyme 2. Severe SARS-CoV-2 infection, also known as coronavirus disease 2019 (COVID-19), can lead to death due to acute respiratory distre...
Autores principales: | Kumar, Rahul, Lee, Michael H., Mickael, Claudia, Kassa, Biruk, Pasha, Qadar, Tuder, Rubin, Graham, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720688/ https://www.ncbi.nlm.nih.gov/pubmed/33313306 http://dx.doi.org/10.1183/23120541.00405-2020 |
Ejemplares similares
-
Paclitaxel blocks Th2-mediated TGF-β activation in
Schistosoma mansoni-induced pulmonary
hypertension
por: Kassa, Biruk, et al.
Publicado: (2018) -
Experimental Schistosoma japonicum-induced pulmonary hypertension
por: Kassa, Biruk, et al.
Publicado: (2022) -
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension
por: Gu, Sue, et al.
Publicado: (2022) -
Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension
por: Kumar, Rahul, et al.
Publicado: (2023) -
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment
por: Hernandez-Saavedra, Daniel, et al.
Publicado: (2020)